These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32234958)
1. Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety. Grant BMM; Enomoto M; Back SI; Lee KY; Gebregiworgis T; Ishiyama N; Ikura M; Marshall CB Sci Signal; 2020 Mar; 13(625):. PubMed ID: 32234958 [TBL] [Abstract][Full Text] [Related]
2. A Non-Canonical Calmodulin Target Motif Comprising a Polybasic Region and Lipidated Terminal Residue Regulates Localization. Grant BMM; Enomoto M; Ikura M; Marshall CB Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326637 [TBL] [Abstract][Full Text] [Related]
3. The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin. Jang H; Banerjee A; Marcus K; Makowski L; Mattos C; Gaponenko V; Nussinov R Structure; 2019 Nov; 27(11):1647-1659.e4. PubMed ID: 31495533 [TBL] [Abstract][Full Text] [Related]
4. KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner. Agamasu C; Ghirlando R; Taylor T; Messing S; Tran TH; Bindu L; Tonelli M; Nissley DV; McCormick F; Stephen AG Biophys J; 2019 Mar; 116(6):1049-1063. PubMed ID: 30846362 [TBL] [Abstract][Full Text] [Related]
5. Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ. Dharmaiah S; Bindu L; Tran TH; Gillette WK; Frank PH; Ghirlando R; Nissley DV; Esposito D; McCormick F; Stephen AG; Simanshu DK Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6766-E6775. PubMed ID: 27791178 [TBL] [Abstract][Full Text] [Related]
6. Interaction of KRas4B protein with C6-ceramide containing lipid model membranes. Li L; Dwivedi M; Erwin N; Möbitz S; Nussbaumer P; Winter R Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1008-1014. PubMed ID: 29357287 [TBL] [Abstract][Full Text] [Related]
7. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ. Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325 [TBL] [Abstract][Full Text] [Related]
8. Organization of Farnesylated, Carboxymethylated KRAS4B on Membranes. Barklis E; Stephen AG; Staubus AO; Barklis RL; Alfadhli A J Mol Biol; 2019 Sep; 431(19):3706-3717. PubMed ID: 31330153 [TBL] [Abstract][Full Text] [Related]
9. Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions. Gillette WK; Esposito D; Abreu Blanco M; Alexander P; Bindu L; Bittner C; Chertov O; Frank PH; Grose C; Jones JE; Meng Z; Perkins S; Van Q; Ghirlando R; Fivash M; Nissley DV; McCormick F; Holderfield M; Stephen AG Sci Rep; 2015 Nov; 5():15916. PubMed ID: 26522388 [TBL] [Abstract][Full Text] [Related]
10. Regulation of K-Ras4B Membrane Binding by Calmodulin. Sperlich B; Kapoor S; Waldmann H; Winter R; Weise K Biophys J; 2016 Jul; 111(1):113-22. PubMed ID: 27410739 [TBL] [Abstract][Full Text] [Related]
11. Both the C-terminal polylysine region and the farnesylation of K-RasB are important for its specific interaction with calmodulin. Wu LJ; Xu LR; Liao JM; Chen J; Liang Y PLoS One; 2011; 6(7):e21929. PubMed ID: 21750741 [TBL] [Abstract][Full Text] [Related]
12. Production and Membrane Binding of N-Terminally Acetylated, C-Terminally Farnesylated and Carboxymethylated KRAS4b. Messing S; Agamasu C; Drew M; DeHart CJ; Stephen AG; Gillette WK Methods Mol Biol; 2021; 2262():105-116. PubMed ID: 33977473 [TBL] [Abstract][Full Text] [Related]
13. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior. Goswami D; Chen D; Yang Y; Gudla PR; Columbus J; Worthy K; Rigby M; Wheeler M; Mukhopadhyay S; Powell K; Burgan W; Wall V; Esposito D; Simanshu DK; Lightstone FC; Nissley DV; McCormick F; Turbyville T Elife; 2020 Jan; 9():. PubMed ID: 31958057 [TBL] [Abstract][Full Text] [Related]
14. Reconstitution and characterization of BRAF in complex with 14-3-3 and KRAS4B on nanodiscs. Liu NF; Enomoto M; Marshall CB; Ikura M Protein Sci; 2024 Jun; 33(6):e5016. PubMed ID: 38747381 [TBL] [Abstract][Full Text] [Related]
15. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers. Nussinov R; Zhang M; Tsai CJ; Jang H Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2304-2314. PubMed ID: 29097261 [TBL] [Abstract][Full Text] [Related]
16. PIP2 Influences the Conformational Dynamics of Membrane-Bound KRAS4b. McLean MA; Stephen AG; Sligar SG Biochemistry; 2019 Aug; 58(33):3537-3545. PubMed ID: 31339036 [TBL] [Abstract][Full Text] [Related]
17. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction. Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230 [TBL] [Abstract][Full Text] [Related]
18. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function. Cao S; Chung S; Kim S; Li Z; Manor D; Buck M J Biol Chem; 2019 Apr; 294(17):7068-7084. PubMed ID: 30792310 [TBL] [Abstract][Full Text] [Related]
19. Exploring CRD mobility during RAS/RAF engagement at the membrane. Nguyen K; López CA; Neale C; Van QN; Carpenter TS; Di Natale F; Travers T; Tran TH; Chan AH; Bhatia H; Frank PH; Tonelli M; Zhang X; Gulten G; Reddy T; Burns V; Oppelstrup T; Hengartner N; Simanshu DK; Bremer PT; Chen D; Glosli JN; Shrestha R; Turbyville T; Streitz FH; Nissley DV; Ingólfsson HI; Stephen AG; Lightstone FC; Gnanakaran S Biophys J; 2022 Oct; 121(19):3630-3650. PubMed ID: 35778842 [TBL] [Abstract][Full Text] [Related]
20. Unveiling the Dynamics of KRAS4b on Lipid Model Membranes. López CA; Agarwal A; Van QN; Stephen AG; Gnanakaran S J Membr Biol; 2021 Apr; 254(2):201-216. PubMed ID: 33825026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]